Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Umbilical Cord Mesenchymal Stem Cell Injection in Type 2 Diabetic Nephropathy
NCT07769671Phase 2Not yet recruiting
- Sponsor
- Changzhou First People's Hospital
- Start
- Sep 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in diabetic nephropathy (DN), sponsored by Changzhou First People's Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT07769671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07769671.